JP2009545598A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545598A5
JP2009545598A5 JP2009522869A JP2009522869A JP2009545598A5 JP 2009545598 A5 JP2009545598 A5 JP 2009545598A5 JP 2009522869 A JP2009522869 A JP 2009522869A JP 2009522869 A JP2009522869 A JP 2009522869A JP 2009545598 A5 JP2009545598 A5 JP 2009545598A5
Authority
JP
Japan
Prior art keywords
alkyl
carbon
hydrogen
substituted
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009522869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009545598A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/017244 external-priority patent/WO2008016675A1/en
Publication of JP2009545598A publication Critical patent/JP2009545598A/ja
Publication of JP2009545598A5 publication Critical patent/JP2009545598A5/ja
Pending legal-status Critical Current

Links

JP2009522869A 2006-08-01 2007-08-01 Ｐ３８キナーゼ阻害剤 Pending JP2009545598A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82111606P 2006-08-01 2006-08-01
PCT/US2007/017244 WO2008016675A1 (en) 2006-08-01 2007-08-01 P38 kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2009545598A JP2009545598A (ja) 2009-12-24
JP2009545598A5 true JP2009545598A5 (https=) 2010-09-16

Family

ID=38705006

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009522869A Pending JP2009545598A (ja) 2006-08-01 2007-08-01 Ｐ３８キナーゼ阻害剤

Country Status (4)

Country Link
US (1) US8119798B2 (https=)
EP (1) EP2059512A1 (https=)
JP (1) JP2009545598A (https=)
WO (1) WO2008016675A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1010887A2 (pt) * 2009-06-08 2016-12-27 California Capital Equity Llc derivados de triazina e suas aplicações terapêuticas.
ES2577829T3 (es) 2010-06-04 2016-07-19 F. Hoffmann-La Roche Ag Derivados de aminopirimidina como moduladores de la LRRK2
NO2638031T3 (https=) 2010-11-10 2018-03-10
US20120295911A1 (en) 2010-11-29 2012-11-22 Galleon Pharmaceuticals, Inc. Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
AU2011336764B2 (en) * 2010-11-29 2017-02-23 Galleon Pharmaceuticals, Inc. Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
CA3120895C (en) 2018-12-20 2024-07-02 Sergey N. Krylov BINDER SELECTION USING CAPILLARY ELECTROPHORESIS
EP3772513A1 (en) * 2019-08-09 2021-02-10 C.N.C.C.S. S.c.a.r.l. Collezione Nazionale Dei Composti Chimici e Centro Screening Shp2 inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036410A1 (en) 1998-01-13 1999-07-22 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
US6262053B1 (en) 1999-06-23 2001-07-17 Parker Hughes Institute Melamine derivatives as potent anti-cancer agents
EP1246823A1 (en) 1999-12-28 2002-10-09 Pharmacopeia, Inc. Pyrimidine and triazine kinase inhibitors
AU2002316421B2 (en) 2001-06-26 2008-05-15 Bristol-Myers Squibb Company N-heterocyclic inhibitors of TNF-ALPHA expression
DE60235470D1 (de) * 2001-06-26 2010-04-08 Pharmacopeia Inc N-heterocyclische inhibitoren der expression von tnf-alpha
US7173032B2 (en) * 2001-09-21 2007-02-06 Reddy Us Therapeutics, Inc. Methods and compositions of novel triazine compounds
AU2002342018A1 (en) 2001-10-12 2003-04-28 New York University Trisubstituted triazines compounds with antitubulin activity
FR2841116B1 (fr) 2002-06-19 2004-11-26 Seb Sa Cafetiere du type expresso a reservoir d'eau amovible
MXPA05007503A (es) 2003-01-17 2005-09-21 Warner Lambert Co Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
CN101180061A (zh) 2005-05-19 2008-05-14 普罗米蒂克生物科学公司 化合物、含有此类化合物的组合物、和治疗转移性黑素瘤和其它癌症的方法
EP2441757A1 (en) * 2006-07-31 2012-04-18 Praecis Pharmaceuticals Incorporated Aurora kinase inhibitors from an encoded small molecule library

Similar Documents

Publication Publication Date Title
JP2009545598A5 (https=)
NZ594332A (en) Compounds for the prevention and treatment of cardiovascular disease
JP2011529049A5 (https=)
WO2012147107A3 (en) Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
EP2620432A3 (en) Diarylhydantoin compounds
SI3009431T1 (en) 2- (2,4,5-substituted-anilino) pyrimidine derivatives, as EGFR modulators useful for the treatment of cancer
JP2016522835A5 (https=)
RU2017127135A (ru) Терапевтическое средство против рака желчных протоков
GEP20125469B (en) Inhibitors of akt activity
JP2015517566A5 (https=)
NZ588830A (en) Inhibitors of protein kinases
JP2014526549A5 (https=)
CA2687265A1 (en) P70 s6 kinase inhibitors
JP2014505107A5 (https=)
JP2016526540A5 (https=)
RU2011108026A (ru) Комбинированная терапия туберкулеза
TW200738729A (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
JP2011513410A5 (https=)
AU2014310371A1 (en) Compositions and therapeutic methods for accelerated plaque regression
TN2012000110A1 (en) N-4 ( - ( ( 3- ( 2 -amino-4 pyrimidinyl) -2 -pyridinyl) oxy) phenyl) -4- (4-methyl-2-thienyl) -1-phthalazinamine for use in the treatment of antimitotic agent resistant cancer
JP2011521938A5 (https=)
JP2006501201A5 (https=)
JP2010522218A5 (https=)
EA200870454A1 (ru) Способ ингибирования c-kit киназы
SI3174881T1 (en) (1,2,4) triazolo (4,3-B) pyridazines for use in the treatment of proliferative diseases